Microtransplantation for myeloid sarcoma: Two case reports

Myeloid sarcoma (MS), is a rare extramedullary tumor with a poor prognosis and high recurrence rate. Microtransplantation is one of the alternative methods of traditional transplantation, which does not rely on HLA complete matching, has low toxicity and may retain part of graft-versus-leukemia (GVL...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xue, Wang, Shuoting, Wang, Fujue, Shen, Qianqing, Jia, Yongqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133757/
https://www.ncbi.nlm.nih.gov/pubmed/35634196
http://dx.doi.org/10.1016/j.lrr.2022.100326
_version_ 1784713640979464192
author Zhang, Xue
Wang, Shuoting
Wang, Fujue
Shen, Qianqing
Jia, Yongqian
author_facet Zhang, Xue
Wang, Shuoting
Wang, Fujue
Shen, Qianqing
Jia, Yongqian
author_sort Zhang, Xue
collection PubMed
description Myeloid sarcoma (MS), is a rare extramedullary tumor with a poor prognosis and high recurrence rate. Microtransplantation is one of the alternative methods of traditional transplantation, which does not rely on HLA complete matching, has low toxicity and may retain part of graft-versus-leukemia (GVL) effect. It has been reported that microtransplantation can significantly improve the survival rate of elderly AML patients. At present, there is no report on the application of micro transplantation in MS. We will report two cases of MS treated by micro transplantation. The disease-free survival was 66 months and 55 months respectively.
format Online
Article
Text
id pubmed-9133757
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-91337572022-05-27 Microtransplantation for myeloid sarcoma: Two case reports Zhang, Xue Wang, Shuoting Wang, Fujue Shen, Qianqing Jia, Yongqian Leuk Res Rep Article Myeloid sarcoma (MS), is a rare extramedullary tumor with a poor prognosis and high recurrence rate. Microtransplantation is one of the alternative methods of traditional transplantation, which does not rely on HLA complete matching, has low toxicity and may retain part of graft-versus-leukemia (GVL) effect. It has been reported that microtransplantation can significantly improve the survival rate of elderly AML patients. At present, there is no report on the application of micro transplantation in MS. We will report two cases of MS treated by micro transplantation. The disease-free survival was 66 months and 55 months respectively. Elsevier 2022-05-21 /pmc/articles/PMC9133757/ /pubmed/35634196 http://dx.doi.org/10.1016/j.lrr.2022.100326 Text en © 2022 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Zhang, Xue
Wang, Shuoting
Wang, Fujue
Shen, Qianqing
Jia, Yongqian
Microtransplantation for myeloid sarcoma: Two case reports
title Microtransplantation for myeloid sarcoma: Two case reports
title_full Microtransplantation for myeloid sarcoma: Two case reports
title_fullStr Microtransplantation for myeloid sarcoma: Two case reports
title_full_unstemmed Microtransplantation for myeloid sarcoma: Two case reports
title_short Microtransplantation for myeloid sarcoma: Two case reports
title_sort microtransplantation for myeloid sarcoma: two case reports
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133757/
https://www.ncbi.nlm.nih.gov/pubmed/35634196
http://dx.doi.org/10.1016/j.lrr.2022.100326
work_keys_str_mv AT zhangxue microtransplantationformyeloidsarcomatwocasereports
AT wangshuoting microtransplantationformyeloidsarcomatwocasereports
AT wangfujue microtransplantationformyeloidsarcomatwocasereports
AT shenqianqing microtransplantationformyeloidsarcomatwocasereports
AT jiayongqian microtransplantationformyeloidsarcomatwocasereports

Ejemplares similares